Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | unknown | Phase 1 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05190653 | Early Integration of Palliative and Supportive Care in Cellular Therapy(PALS_CT) | unknown | N/A | 152 | Alberta Health Services, CalgaryOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05214612 | Predictors and Prognostic Factors of Myasthenia Gravis Outcome | unknown | — | 30 | Assiut UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05412589 | mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC | unknown | Phase 2 | 35 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06234579 | Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)(GALILEO) | unknown | — | 108 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06530771 | Multimodality US Based on Angio Planewave Ultrasensitive Imaging and Shear Wave Elastography to Evaluate the Malignancy Risk Value of Thyroid Nodules | unknown | — | 720 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06530784 | Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma | unknown | Phase 2 | 36 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06530797 | A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer | unknown | — | 2,000 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 0 | Jul 31, 2024 | clinicaltrials |
| NCT03244176 | Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study(AvR-CHOP) | unknown | Early Phase 1 | 28 | Austin HealthOTHER_GOV | 1 | Jul 30, 2024 | clinicaltrials |
| NCT03366051 | Sentinel Node Mapping in High Risk Endometrial Cancer(ALICE) | unknown | N/A | 178 | AC Camargo Cancer CenterOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT04679480 | Anti-PD1-antibody and Pulsed HHI for Advanced BCC | unknown | Phase 2 | 20 | Reinhard DummerOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT05801406 | From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.(Vortex_US) | unknown | — | 5 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT05822934 | Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | unknown | Phase 3 | 20 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT05919758 | Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix(NETkids) | unknown | — | 1,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06128694 | Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients | unknown | Phase 3 | 108 | Kalbe International Pte. LtdINDUSTRY | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06427330 | Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia | unknown | Phase 2 | 21 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06526832 | A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer | unknown | Phase 1 | 9 | BioSyngen Pte LtdINDUSTRY | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06527495 | Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 150 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06528054 | TreatmENT of AnastomotiC LeakagE After COLON Cancer Resection(TENTACLE-Colon) | unknown | — | 2,000 | Radboud University Medical CenterOTHER | 0 | Jul 30, 2024 | clinicaltrials |
| NCT05638269 | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | unknown | — | 12,000 | Zhujiang HospitalOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT05842785 | TSN222 in Subjects With Advanced Solid Tumors or Lymphomas | unknown | Phase 1 / Phase 2 | 162 | Tyligand Bioscience (Shanghai) LimitedINDUSTRY | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06386705 | TSN084 Treating Patients With Advanced Malignant Tumors | unknown | Phase 1 | 114 | Tyligand Bioscience (Shanghai) LimitedINDUSTRY | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06521528 | A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test | unknown | — | 237 | Novomics. Co., Ltd.INDUSTRY | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06524362 | Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled Trial(PERECARE) | unknown | N/A | 77 | GEM Hospital & Research CenterOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06524557 | Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors | unknown | — | 200 | Xijing HospitalOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT04823403 | Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma(HIPANIV) | unknown | Phase 1 | 27 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06199908 | AMT-562 in Patients With Selected Advanced Solid Tumors | unknown | Phase 1 | 72 | Multitude Therapeutics (Australia) Pty LtdINDUSTRY | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06515678 | Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension(IATRO) | unknown | — | 9,464 | Groupe Hospitalier Pitie-SalpetriereOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06521541 | Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy | unknown | N/A | 90 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06521684 | Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma | unknown | — | 110 | Peking Union Medical College HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT06521697 | Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery | unknown | Phase 4 | 60 | National Taiwan University HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT06522542 | Gastric Cancer Complicated With Bleeding | unknown | — | 200 | Peking University Third HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT06523322 | Culinary Medicine for Cancer Caregivers | unknown | N/A | 20 | Drexel UniversityOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT06523452 | Laser Speckle Imaging During Breast Reconstruction(SIMBAR) | unknown | N/A | 60 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06523933 | Distribution of Bacteria in OME After Radiotherapy For NPC. | unknown | — | 234 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT05554276 | Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer(PD-1) | unknown | Phase 2 | 36 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT06511661 | Prognostic Significance of the Uncertain Resection in NSCLC | unknown | — | 3,783 | Sun Yat-sen UniversityOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT06519006 | Effectiveness of Pelvic Floor Exercise to Prevent LARS (Low Anterior Resection Syndrome)(CH1) | unknown | N/A | 50 | F. D. Roosevelt University HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT06519110 | Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations(CVL009-C2001) | unknown | Phase 2 | 60 | Convalife (Shanghai) Co., Ltd.INDUSTRY | 0 | Jul 25, 2024 | clinicaltrials |
| NCT06520319 | Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma | unknown | Phase 1 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT05707325 | Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies(Reboot-101) | unknown | Early Phase 1 | 30 | Westlake TherapeuticsINDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT05803928 | Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies | unknown | Phase 1 | 70 | Hua LiOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT05839834 | Blood Cell RNA-Based Cancer Detection(eRBCDet) | unknown | — | 5,000 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT05883683 | Molecular Study and Precision Medicine for Colorectal Cancer(MSPM) | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06237491 | The Safety and Dosimetry Study of 177Lu-LNC1003 Injection | unknown | Phase 1 | 12 | Yantai LNC Biotechnology Singapore PTE. LTD.INDUSTRY | 0 | Jul 24, 2024 | clinicaltrials |
| NCT06256055 | Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors | unknown | Phase 1 | 24 | UTC Therapeutics Inc.INDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06479460 | Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients | unknown | — | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06516445 | SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC | unknown | Phase 2 | 33 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06517992 | Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)(Communicated) | unknown | N/A | 80 | Gadjah Mada UniversityOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT04503148 | Anesthesia and Cancer Study: Renal Cell Carcinoma | unknown | N/A | 562 | Seoul National University HospitalOTHER | 1 | Jul 23, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jul 31, 2024source: clinicaltrials